Back
Karyopharm Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
KPTI
Karyopharm Therapeutics
Last Price:
$5.17
Seasonality Move:
-5.11%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight buying pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.5 | Sell |
| 20-day SMA: | 6.03 | Sell |
| 50-day SMA: | 5.51 | Sell |
| 200-day SMA: | 9.79 | Sell |
| 8-day EMA: | 5.48 | Sell |
| 20-day EMA: | 5.66 | Sell |
| 50-day EMA: | 6.06 | Sell |
| 200-day EMA: | 9.72 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 43.51 | Sell |
| Chaikin Money Flow: | 13978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.92 - 6.58) | Sell |
| Bollinger Bands (100): | (5.16 - 9.84) | Sell |
Karyopharm Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 5.13 while KPTI 8-day simple moving average is 5.50, which is a Sell signal.
-
The stock price of KPTI is 5.13 while Karyopharm Therapeutics 20-day SMA is 6.03, which makes it a Sell.
-
Karyopharm Therapeutics 50-day simple moving average is 5.51 while KPTI share price is 5.13, making it a Sell technically.
-
KPTI stock price is 5.13 and Karyopharm Therapeutics 200-day simple moving average is 9.79, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
38
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $5.13. The Score for KPTI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
44.3M
Price in USD:
5.13
Share Volume:
58.5K
Karyopharm Therapeutics 52-Week Range
52-Week High:
17.85
52-Week Low:
3.51
Sell
38
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 5.13 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 5.13 while KPTI 8-day exponential moving average is 5.48, which is a Sell signal.
-
The stock price of KPTI is 5.13 while Karyopharm Therapeutics 20-day EMA is 5.66, which makes it a Sell.
-
Karyopharm Therapeutics 50-day exponential moving average is 6.06 while KPTI share price is 5.13, making it a Sell technically.
-
KPTI stock price is 5.13 and Karyopharm Therapeutics 200-day simple moving average is 9.72, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $2.02 per share, an increase this year of $0.39 per share, and an increase next year of $5.80 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Karyopharm Therapeutics is a Sell
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 43.51, which suggest Karyopharm Therapeutics is oversold
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (4.92 - 6.58), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (5.16 - 9.84), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.